Your Blood Pressure Won't Drop. Here's the Biological Reason.

The ACE gene produces an enzyme that converts angiotensin I into angiotensin II, a potent vasoconstrictor. This hormone tells your blood vessels to tighten, raising pressure. ACE also influences how much your heart muscle grows in response to pressure load. In a healthy system, ACE activity rises and falls with your body’s needs, maintaining a dynamic balance.

The ACE gene has a common polymorphism called the I/D (insertion/deletion) variant. The D allele is associated with higher ACE activity. People with the D/D genotype, which accounts for roughly 25% of the population, produce more ACE enzyme and therefore more angiotensin II. This higher baseline of ACE activity means your blood vessels constrict more aggressively and your blood pressure baseline is shifted upward. The effect is modest but measurable: D/D carriers average 5-10 mmHg higher systolic pressure.

If you carry the D/D variant, you’re living with a system that’s biologically primed to maintain higher pressure. You feel fine most of the time; your body has adapted. But during stress, salt loading, or poor sleep, that pressure jumps more dramatically than it would for an I/I carrier. You’re also at higher risk for left ventricular hypertrophy, a thickening of the heart muscle that stiffens the heart and reduces its efficiency over time.

The AGT gene produces angiotensinogen, the precursor that ACE converts into angiotensin II. If ACE is the enzyme that pulls the trigger, AGT is the ammunition. More angiotensinogen means more substrate available for conversion to the vasoconstrictor angiotensin II. The more raw material your body produces, the higher your baseline pressure tends to be.

The M235T variant in AGT is extremely common. The T allele is associated with higher angiotensinogen production. Roughly 40% of people carry at least one T allele. If you’re homozygous T/T, your baseline angiotensinogen production is elevated, which drives persistent higher blood pressure and increases sodium retention. The effect is compounded when combined with other pressure-raising variants.

You experience this as a baseline elevation: your resting blood pressure sits 10-15 mmHg higher than it “should.” When you eat salty food, your pressure spikes higher and takes longer to return to baseline. You may also notice that you retain fluid more easily, feel more bloated after high-sodium meals, or have puffiness in your ankles or face by evening. These are all consequences of your body retaining sodium in response to excess angiotensin II signaling.

The AGTR1 gene produces the receptor that catches angiotensin II and tells blood vessels to constrict. Think of it as the lock, and angiotensin II as the key. If your receptors are more sensitive, the same amount of angiotensin II produces a stronger constriction response. This is independent of how much angiotensin II your body produces; it’s about how aggressively your blood vessels respond to it.

The A1166C variant in AGTR1 affects receptor sensitivity. The C allele, carried by roughly 30% of the population, is associated with higher receptor sensitivity. People with one or two C alleles experience more potent blood vessel constriction in response to angiotensin II, resulting in higher resting blood pressure and exaggerated pressure spikes during stress. The effect is especially pronounced when combined with AGT T alleles.

You feel this as hair-trigger blood pressure responses. A stressful conversation at work, a difficult email, a deadline approaching: your pressure spikes more dramatically and stays elevated longer than your friends’ would. You may also notice your pressure is particularly sensitive to caffeine or stimulating situations. Your blood vessels are simply more reactive to the signals being sent.

The ADD1 gene produces alpha-adducin, a protein that sits on the surface of kidney tubule cells and regulates how much sodium gets reabsorbed back into your bloodstream. When sodium is reabsorbed, water follows osmotically. More sodium retention means more fluid in your bloodstream, which means higher blood pressure. ADD1 variants directly determine your baseline sodium sensitivity.

The G460W variant in ADD1 is common. The W allele, carried by roughly 25% of the population, is associated with increased sodium reabsorption. People with the W/W genotype or W/G carriers retain more sodium in response to dietary salt intake, which increases blood volume and elevates blood pressure. This effect is magnified in people eating high-sodium diets and is one of the primary genetic determinants of salt sensitivity.

You experience this as genuine sodium sensitivity. When you eat salty food, you retain fluid noticeably: your ankles swell, your face puffs up, your rings get tight. Your weight can swing 2-3 pounds day to day based on sodium intake. Even a single high-sodium meal can bump your blood pressure up 10-20 mmHg. You’re not imagining this connection; your kidneys are genuinely sensitive to sodium because of how your ADD1 protein functions.

The CYP11B2 gene produces the enzyme that makes aldosterone, a hormone that tells your kidneys to hold onto sodium and excrete potassium. Aldosterone is your body’s primary sodium-retention hormone. When aldosterone is elevated, you retain more salt and fluid, your blood pressure rises, and your potassium levels drop. CYP11B2 variants directly influence how much aldosterone your adrenal glands produce.

The -344C>T variant in CYP11B2 is very common. The T allele, carried by roughly 40% of the population, is associated with higher aldosterone production. People homozygous for the T allele produce more aldosterone, which increases sodium retention, raises blood volume, and elevates blood pressure independent of salt intake. Some people with this variant develop hypokalemia (low potassium), which causes muscle weakness, cramping, and irregular heartbeats.

You might experience this as persistent fluid retention despite low-sodium diet. Your blood pressure stays elevated even when you’ve cut salt significantly. You feel fatigued, have muscle cramps or weakness, or experience heart palpitations, especially if you’re also taking a diuretic (which causes further potassium loss). These are signs of elevated aldosterone and depleted potassium, a combination that’s dangerous if left unaddressed.

The NOS3 gene produces endothelial nitric oxide synthase, an enzyme that manufactures nitric oxide in the inner lining of your blood vessels. Nitric oxide is a signaling molecule that tells blood vessels to relax and dilate, allowing blood to flow more easily. It’s the reason certain blood pressure medications work: they increase available nitric oxide. When NOS3 function is impaired, your blood vessels don’t relax as easily, and pressure stays elevated.

The Glu298Asp variant in NOS3 reduces the enzyme’s activity. Roughly 30-40% of people carry this variant. People with the Asp/Asp genotype produce less nitric oxide, impairing blood vessel dilation and causing baseline blood pressure elevation and increased atherosclerosis risk. This variant is particularly significant because it affects vascular function at a fundamental level: your blood vessels simply don’t relax as readily as they should.

You feel this as persistently elevated pressure despite adequate exercise. You might exercise regularly, eat well, manage stress, and yet your pressure remains high. The problem isn’t your lifestyle; it’s that your blood vessels don’t respond to signals to relax. You may also notice poor exercise capacity or fatigue after exertion because your blood vessels can’t dilate fully to deliver oxygen-rich blood to your muscles. Over time, chronic impaired nitric oxide production contributes to atherosclerosis, increasing your long-term cardiovascular risk.